Grifols | GRFS - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Alaunos Therapeutics USD 595K 218K 2026-03
Arca Biopharma USD 22.97M 6.34M 2026-06
aTyr Pharma USD 11.4M 303K 2026-06
Bio Path USD 9.15M 468K 2026-03
Brainstorm Cell Therapeutics USD 11.76M 757K 2026-03
Capricor Therapeutics USD 33.64M 2.2M 2026-03
Cara Therapeutics USD 11.26M 216K 2026-03
GlaxoSmithKline GBP 21.53B 895M 2026-06
Grifols EUR 2.37B 156.97M 2025-12
Immunic USD 38.36M 7.74M 2026-03
Minerva Neurosciences USD 2.29M 381K 2025-12
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Sangamo BioSciences USD 47.66M 1.9M 2025-06
TherapeuticsMD USD 5.82M 655K 2024-06